Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy
Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Josep M. Gatell(Hospital Clínic de Barcelona), Mireia Arnedo(Escuela Nacional de Sanidad), José Alcamı́(Apple (Israel)), Peré Domingo(Hospital de Sant Pau), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Francesc Villarroya(Centro de Investigación Biomédica en Red), Joaquim Peraire(Instituto de Salud Carlos III), Manuel Leal(Apple (Israel))
Cited by 9
Related Papers
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
|Nature Communications|2013|371
Ultraviolet vision in lizards
|Nature|1993|257
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143